-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation